Nantahala Capital Management - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 29 filers reported holding ACER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$748,454
-28.7%
918,349
-19.2%
0.06%
-36.6%
Q2 2023$1,049,367
+15.0%
1,136,416
-5.5%
0.10%
+44.3%
Q1 2023$912,571
-70.3%
1,203,126
-1.9%
0.07%
-64.8%
Q4 2022$3,077,739
+217.9%
1,226,191
+76.0%
0.20%
+215.9%
Q3 2022$968,000
+3.6%
696,538
-6.0%
0.06%
+34.0%
Q2 2022$934,000
-58.6%
741,010
-4.7%
0.05%
-53.0%
Q1 2022$2,256,000
+9.8%
777,820
-13.7%
0.10%
+38.9%
Q4 2021$2,055,000
-12.2%
901,290
-1.4%
0.07%
-2.7%
Q3 2021$2,340,000
-12.5%
914,197
-2.2%
0.07%
-2.6%
Q2 2021$2,673,000
-8.0%
934,7550.0%0.08%
-10.6%
Q1 2021$2,907,000
+12.1%
934,755
-5.6%
0.08%
+6.2%
Q4 2020$2,593,000
-9.1%
989,755
-0.1%
0.08%
-8.0%
Q3 2020$2,853,000
-16.0%
990,6550.0%0.09%
-14.7%
Q2 2020$3,398,000
+72.4%
990,6550.0%0.10%
+37.8%
Q1 2020$1,971,000
-50.4%
990,6550.0%0.07%
-39.3%
Q4 2019$3,973,000
+25.7%
990,6550.0%0.12%
+4.3%
Q3 2019$3,160,000
-18.2%
990,6550.0%0.12%
-1.7%
Q2 2019$3,864,000
-82.0%
990,655
+12.0%
0.12%
-82.2%
Q1 2019$21,492,000
+18.2%
884,455
-2.1%
0.67%
+19.9%
Q4 2018$18,178,000
-14.7%
903,455
+30.7%
0.56%
-2.6%
Q3 2018$21,322,000
+294.5%
691,388
+176.3%
0.57%
+162.1%
Q2 2018$5,405,000
+12.1%
250,2520.0%0.22%
+0.9%
Q1 2018$4,822,000250,2520.22%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 991,568$808,1280.22%
Nantahala Capital Management 918,349$748,4540.06%
Union Square Park Capital Management, LLC 26,633$21,7060.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$490.01%
TUDOR INVESTMENT CORP ET AL 927,041$755,5380.01%
Virtu Financial LLC 61,115$500.01%
HRT FINANCIAL LP 80,720$660.00%
CSS LLC/IL 11,357$9,2560.00%
UBS Group AG 94$770.00%
CSS LLC/IL 2,000$1,6300.00%
View complete list of ACER THERAPEUTICS INC shareholders